JCVI advice to mitigate impact of B1.617.2 variant

The Joint Committee on Vaccination and Immunisation (JCVI) has issued advice to the government on the use of COVID-19 vaccines to mitigate the impact of the B1.617.2 variant of concern.

Read the original advice at Foreign Travel Advice (UK)